Loraine Campanati

Dr. Loraine Campanati

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2016 in Viruses
Verified
Journal Article
Open access
PDF file
RDRodrigo Delvecchio
Rodrigo Delvecchio
LHLuiza Higa
Luiza Higa
PPPaula Pezzuto
Paula Pezzuto
AVAna Luiza Valadão
Ana Luiza Valadão
PGPatricia Pestana Garcez
Patricia Pestana Garcez
ATAmilcar Tanuri
Amilcar Tanuri
Zika virus (ZIKV) infection in utero might lead to microcephaly and other congenital defects. Since no specific therapy is available thus far, there is an urgent need for the discovery of agents capable of inhibiting its viral replication and deleterious effects. Chloroquine is widely used as an antimalarial drug, anti-inflammatory agent, and it also shows antiviral activity against several viruses. Here we show that chloroquine exhibits antiviral activity against ZIKV in Vero cells, human brain microvascular endothelial cells, human neural stem cells, and mouse neurospheres. We demonstrate that chloroquine reduces the number of ZIKV-infected cells in vitro, and inhibits virus production and cell death promoted by ZIKV infection without cytotoxic effects. In addition, chloroquine treatment partially reveres morphological changes induced by ZIKV infection in mouse neurospheres.

2 May 2016 in bioRxiv
Verified
Preprint
Open access
PDF file
RDRodrigo Delvecchio
Rodrigo Delvecchio
LHLuiza Higa
Luiza Higa
PPPaula Pezzuto
Paula Pezzuto
AVAna Luiza Valadão
Ana Luiza Valadão
PGPatricia Pestana Garcez
Patricia Pestana Garcez
ATAmilcar Tanuri
Amilcar Tanuri
Summary: Zika virus (ZIKV) infection in utero might lead to microcephaly and other congenital defects. In adults, cases of Guillain-Barré syndrome and meningoencephalitis associated with ZIKV infection have been reported, and no specific therapy is available so far. There is urgency for the discovery of antiviral agents capable of inhibiting viral replication and its deleterious effects. Chloroquine is widely administered as an antimalarial drug, anti-inflammatory agent, and it also shows antiviral activity against several viruses. Here we show that chloroquine exhibits antiviral activity against ZIKV in VERO, human brain microvascular endothelial, and neural stem cells. We demonstrated in vitro that chloroquine reduces the number of ZIKV-infected cells, virus production and cell death promoted by ZIKV infection without cytotoxic effects. Our results suggest that chloroquine is a promising candidate for ZIKV clinical trials, since it is already approved for clinical use and can be safely administered to pregnant woman.

20 April 2010 in Parasitology Research
Verified
Journal Article
Closed access
PDF file
LTLetícia L. Terra
Letícia L. Terra
LCLoraine Campanati
Loraine Campanati
WSWanderley De Souza
Wanderley De Souza

17 June 2016 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
MOMaria Cecilia Oliveira-Nunes
Maria Cecilia Oliveira-Nunes
SKSuzana Assad Kahn
Suzana Assad Kahn
ABAna Luiza de Oliveira Barbeitas
Ana Luiza de Oliveira Barbeitas
TSTania Cristina Leite de Sampaio e Spohr
Tania Cristina Leite de Sampaio e Spohr
LDLuiz Gustavo Feijó Dubois
Luiz Gustavo Feijó Dubois
Katia CarneiroKatia Carneiro
Katia Carneiro
Glioblastoma (GBM) is the most common primary brain tumor presenting self-renewing cancer stem cells. The role of these cells on the development of the tumors has been proposed to recapitulate programs from embryogenesis. Recently, the embryonic transforming growth factor-β (TGF-β) protein Nodal has been shown to be reactivated upon tumor development; however, its availability in GBM cells has not been addressed so far. In this study, we investigated by an original approach the mechanisms that dynamically control both intra and extracellular Nodal availability during GBM tumorigenesis. We characterized the dynamics of Nodal availability in both stem and more differentiated GBM cells through morphological analysis, immunofluorescence of Nodal protein and of early (EEA1 and Rab5) and late (Rab7 and Rab11) endocytic markers and Western Blot. Tukey’s test was used to analyze the prevalent correlation of Nodal with different endocytic markers inside specific differentiation states, and Sidak’s multiple comparisons test was used to compare the prevalence of Nodal/endocytic markers co-localization between two differentiation states of GBM cells. Paired t test was used to analyze the abundance of Nodal protein, in extra and intracellular media. The cytoplasmic distribution of Nodal was dynamically regulated and strongly correlated with the differentiation status of GBM cells. While Nodal-positive vesicle-like particles were symmetrically distributed in GBM stem cells (GBMsc), they presented asymmetric perinuclear localization in more differentiated GBM cells (mdGBM). Strikingly, when subjected to dedifferentiation, the distribution of Nodal in mdGBM shifted to a symmetric pattern. Moreover, the availability of both intracellular and secreted Nodal were downregulated upon GBMsc differentiation, with cells becoming elongated, negative for Nodal and positive for Nestin. Interestingly, the co-localization of Nodal with endosomal vesicles also depended on the differentiation status of the cells, with Nodal seen more packed in EEA1/Rab5 + vesicles in GBMsc and more in Rab7/11 + vesicles in mdGBM. Our results show for the first time that Nodal availability relates to GBM cell differentiation status and that it is dynamically regulated by an endocytic pathway during GBM tumorigenesis, shedding new light on molecular pathways that might emerge as putative targets for Nodal signaling in GBM therapy.

31 March 2016 in bioRxiv
Verified
Preprint
Open access
PDF file
LCLoraine Campanati
Loraine Campanati
LHLuiza Higa
Luiza Higa
RDRodrigo Delvecchio
Rodrigo Delvecchio
PPPaula Pezzuto
Paula Pezzuto
AVAna Luiza Valadão
Ana Luiza Valadão
ATAmilcar Tanuri
Amilcar Tanuri
In the last few months, an overwhelming number of people have been exposed to the Zika virus (ZIKV) in South and Central America. Here we showed, in vitro , that a Brazilian isolate impacts more severely murine neuronal progenitors and neurons than the African strain MR766. We found that the Brazilian isolate more pronouncedly inhibits neurite extension from neurospheres, alters their differentiation potential and causes neurons to have less and shorter processes. Comparing both lineages using a panel of inflammatory cytokines, we showed, with human neuroblastoma cells, that ZIKV induces the production of several inflammatory and chemotactic cytokines and once again, the Brazilian isolate had a more significant impact. Although much more needs to be studied regarding the association of ZIKV infection and brain damage during development, our study sheds some light into the differences between African and American lineages and the mechanisms by which the virus may be affecting neurogenesis.